🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 hora
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/12/1992 | 22,60 | 22,78 | 22,48 | 22,60 | -0,26% | 1,32% | 2.409.352 |
| 11/12/1992 | 22,48 | 22,66 | 22,42 | 22,66 | +0,80% | 1,06% | 2.708.242 |
| 10/12/1992 | 22,60 | 22,66 | 22,30 | 22,48 | -1,05% | 1,58% | 3.671.563 |
| 09/12/1992 | 22,42 | 22,72 | 22,36 | 22,72 | +1,87% | 1,60% | 5.320.486 |
| 08/12/1992 | 22,19 | 22,48 | 22,19 | 22,30 | +0,54% | 1,34% | 4.601.349 |
| 07/12/1992 | 21,89 | 22,19 | 21,59 | 22,19 | +1,64% | 2,72% | 3.977.789 |
| 04/12/1992 | 21,83 | 22,07 | 21,77 | 21,83 | -0,27% | 1,37% | 3.562.152 |
| 03/12/1992 | 21,77 | 21,89 | 21,53 | 21,89 | +0,55% | 1,64% | 3.030.397 |
| 02/12/1992 | 21,83 | 21,89 | 21,65 | 21,77 | -0,27% | 1,09% | 2.827.504 |
| 01/12/1992 | 21,53 | 21,83 | 21,47 | 21,83 | +1,39% | 1,66% | 3.503.674 |
| 30/11/1992 | 21,83 | 21,83 | 21,41 | 21,53 | -1,37% | 1,91% | 3.748.906 |
| 27/11/1992 | 21,71 | 21,89 | 21,65 | 21,83 | +0,83% | 1,10% | 1.735.698 |
| 25/11/1992 | 21,59 | 21,71 | 21,47 | 21,65 | +0,55% | 1,10% | 3.569.069 |
| 24/11/1992 | 21,59 | 21,71 | 21,41 | 21,53 | -0,55% | 1,38% | 4.104.597 |
| 23/11/1992 | 21,95 | 22,01 | 21,53 | 21,65 | -1,63% | 2,17% | 3.653.957 |
| 20/11/1992 | 22,24 | 22,24 | 22,01 | 22,01 | -0,27% | 1,07% | 5.283.597 |
| 19/11/1992 | 22,24 | 22,24 | 21,95 | 22,07 | -0,54% | 1,34% | 3.532.808 |
| 18/11/1992 | 22,01 | 22,24 | 21,95 | 22,19 | +1,36% | 1,36% | 3.766.931 |
| 17/11/1992 | 21,77 | 21,89 | 21,53 | 21,89 | +0,82% | 1,64% | 3.132.472 |
| 16/11/1992 | 21,71 | 21,83 | 21,53 | 21,71 | +0,00% | 1,37% | 2.899.816 |
| 13/11/1992 | 21,77 | 21,83 | 21,23 | 21,71 | -0,55% | 2,74% | 4.842.389 |
| 12/11/1992 | 21,59 | 22,01 | 21,59 | 21,83 | +1,95% | 1,93% | 7.084.480 |
| 11/11/1992 | 20,57 | 21,47 | 20,52 | 21,41 | +4,66% | 4,64% | 8.543.715 |
| 10/11/1992 | 20,34 | 20,57 | 20,16 | 20,46 | +1,78% | 2,05% | 4.814.512 |
| 09/11/1992 | 20,04 | 20,34 | 19,92 | 20,10 | +0,00% | 2,08% | 4.781.814 |
| 06/11/1992 | 20,10 | 20,10 | 19,74 | 20,10 | -0,30% | 1,78% | 6.386.512 |
| 05/11/1992 | 20,52 | 20,69 | 20,04 | 20,16 | -1,74% | 3,20% | 5.926.230 |
| 04/11/1992 | 20,87 | 20,99 | 20,40 | 20,52 | -2,27% | 2,86% | 3.806.126 |
| 03/11/1992 | 21,41 | 21,47 | 20,87 | 20,99 | -1,40% | 2,79% | 3.884.517 |
| 02/11/1992 | 20,87 | 21,47 | 20,69 | 21,29 | +1,71% | 3,71% | 5.185.294 |